chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Guillain-Barre syndrome, Headache, Herpes simplex test negative, Hypoaesthesia, Immunoglobulin therapy
Clinical narrative: I was diagnosed with Guillain-Barre syndrome as a result of taking the J&J vaccine. Symptoms started about two weeks after the shot. I first felt tingling in the arms and legs as well as loss of taste on the tongue and then, a few days later, the left side of my face became numb and immobile. A few days after I was diagnosed with Bell's Palsy (after hours spent in the emergency room) and prescribed Prednisone and Valtrax to improve the symptoms, the symptoms got worse and spread to the right side of my face, as well. My entire face was immobile and numb (along with the tingling in my arms and legs). The neurologist I saw, who had originally diagnosed me with Bell's Palsy saw me in his office that same day (when the right side of my face became immobile) and sent me back to the emergency room to get treatment and help. He believed that I had Guillain-Barre syndrome, which is what it turned out to be. I was sent in an ambulance up to Hospital where I sat in the ER for five hours waiting to be seen before they performed a spinal tap to see if I had elevated protein in my spinal fluid. I did have elevated proteins in my spinal fluid, which led the neurology team to believe that I had Guillain-Barre syndrome. I was then admitted to to the hospital for six days during which I would undergo five days of IVIG treatment (ALL OF WHICH, WHILE 28-weeks PREGNANT!!!! which also added a HUGE layer of stress to the situation). I stayed in the hospital from Monday through Saturday to undergo the treatment. It is extremely discouraging and sad what happened as a result of me taking the J&J vaccine. This diagnosis has been extremely scary and I have no idea what kind of effect the treatment that I have had to undergo has had on my baby. This is extremely upsetting and demoralizing. I went through a terrible experience as a result of taking the J&J vaccine and I also have terrible lingering effects - I still have facial immobility and partial paralysis, I have complete loss of taste in my mouth/on my tongue, and I have the worst headaches known to mankind - all as a result of the nerve damage I have suffered as a result of the vaccine giving me GB syndrome. The J&J vaccine has really turned my life upside down. I am due to deliver my baby on July 29th, 2021 and sure hope that everything is okay with the baby after this horrific experience. This is my first pregnancy, so you can imagine how this event as a result of the J&J vaccine has affected me. It's been awful.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Laboratory test, Lumbar puncture abnormal, Nerve injury, Paraesthesia, Stress
Clinical narrative: I was diagnosed with Guillain-Barre syndrome as a result of taking the J&J vaccine. Symptoms started about two weeks after the shot. I first felt tingling in the arms and legs as well as loss of taste on the tongue and then, a few days later, the left side of my face became numb and immobile. A few days after I was diagnosed with Bell's Palsy (after hours spent in the emergency room) and prescribed Prednisone and Valtrax to improve the symptoms, the symptoms got worse and spread to the right side of my face, as well. My entire face was immobile and numb (along with the tingling in my arms and legs). The neurologist I saw, who had originally diagnosed me with Bell's Palsy saw me in his office that same day (when the right side of my face became immobile) and sent me back to the emergency room to get treatment and help. He believed that I had Guillain-Barre syndrome, which is what it turned out to be. I was sent in an ambulance up to Hospital where I sat in the ER for five hours waiting to be seen before they performed a spinal tap to see if I had elevated protein in my spinal fluid. I did have elevated proteins in my spinal fluid, which led the neurology team to believe that I had Guillain-Barre syndrome. I was then admitted to to the hospital for six days during which I would undergo five days of IVIG treatment (ALL OF WHICH, WHILE 28-weeks PREGNANT!!!! which also added a HUGE layer of stress to the situation). I stayed in the hospital from Monday through Saturday to undergo the treatment. It is extremely discouraging and sad what happened as a result of me taking the J&J vaccine. This diagnosis has been extremely scary and I have no idea what kind of effect the treatment that I have had to undergo has had on my baby. This is extremely upsetting and demoralizing. I went through a terrible experience as a result of taking the J&J vaccine and I also have terrible lingering effects - I still have facial immobility and partial paralysis, I have complete loss of taste in my mouth/on my tongue, and I have the worst headaches known to mankind - all as a result of the nerve damage I have suffered as a result of the vaccine giving me GB syndrome. The J&J vaccine has really turned my life upside down. I am due to deliver my baby on July 29th, 2021 and sure hope that everything is okay with the baby after this horrific experience. This is my first pregnancy, so you can imagine how this event as a result of the J&J vaccine has affected me. It's been awful.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Viral test negative
Clinical narrative: I was diagnosed with Guillain-Barre syndrome as a result of taking the J&J vaccine. Symptoms started about two weeks after the shot. I first felt tingling in the arms and legs as well as loss of taste on the tongue and then, a few days later, the left side of my face became numb and immobile. A few days after I was diagnosed with Bell's Palsy (after hours spent in the emergency room) and prescribed Prednisone and Valtrax to improve the symptoms, the symptoms got worse and spread to the right side of my face, as well. My entire face was immobile and numb (along with the tingling in my arms and legs). The neurologist I saw, who had originally diagnosed me with Bell's Palsy saw me in his office that same day (when the right side of my face became immobile) and sent me back to the emergency room to get treatment and help. He believed that I had Guillain-Barre syndrome, which is what it turned out to be. I was sent in an ambulance up to Hospital where I sat in the ER for five hours waiting to be seen before they performed a spinal tap to see if I had elevated protein in my spinal fluid. I did have elevated proteins in my spinal fluid, which led the neurology team to believe that I had Guillain-Barre syndrome. I was then admitted to to the hospital for six days during which I would undergo five days of IVIG treatment (ALL OF WHICH, WHILE 28-weeks PREGNANT!!!! which also added a HUGE layer of stress to the situation). I stayed in the hospital from Monday through Saturday to undergo the treatment. It is extremely discouraging and sad what happened as a result of me taking the J&J vaccine. This diagnosis has been extremely scary and I have no idea what kind of effect the treatment that I have had to undergo has had on my baby. This is extremely upsetting and demoralizing. I went through a terrible experience as a result of taking the J&J vaccine and I also have terrible lingering effects - I still have facial immobility and partial paralysis, I have complete loss of taste in my mouth/on my tongue, and I have the worst headaches known to mankind - all as a result of the nerve damage I have suffered as a result of the vaccine giving me GB syndrome. The J&J vaccine has really turned my life upside down. I am due to deliver my baby on July 29th, 2021 and sure hope that everything is okay with the baby after this horrific experience. This is my first pregnancy, so you can imagine how this event as a result of the J&J vaccine has affected me. It's been awful.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaphylactic reaction, Angioedema, Dysphagia, Intensive care, Swollen tongue
Clinical narrative: Tongue started to swell in waiting lot, went to ER and was kept overnight for observation but in the night tongue and throat began to swell.  Transferred to ICU for 2 days couldn't get swelling down had to be place on an epi pump, histamines and steroids and then swelling decreased and was able to decrease swelling and then was released.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Intensive care, Laboratory test, Pharyngeal swelling, Swollen tongue
Clinical narrative: Tongue started to swell in waiting lot, went to ER and was kept overnight for observation but in the night tongue and throat began to swell.  Transferred to ICU for 2 days couldn't get swelling down had to be place on an epi pump, histamines and steroids and then swelling decreased and was able to decrease swelling and then was released.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acoustic stimulation tests, Hyperacusis, Loss of personal independence in daily activities, Sleep disorder, Tinnitus
Clinical narrative: Tinnitus got worse; This is a spontaneous report from a Non-contactable consumer(patient). A male patient0 of an unspecified age received first dose of bnt162b2 (BNT162B2, Formulation: solution for injection, Lot number : not reported) via an unspecified route of administration on 13Apr2021 as SINGLE DOSE for covid-19 immunisation. Medical history included tinnitus from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported.  On 18Apr2021, The patient experienced tinnitus got worsened and ringing in his ears has become very loud. He wanted to know if this was associated with the vaccine. He was scheduled to receive the 2nd dose of the Pfizer-BioNTech Covid-19 Vaccine in the middle of this month. The patient wants to know if the 2nd dose of the Pfizer-BioNTech Covid-19 Vaccine can be given later than 3 weeks. He also wants to know if it would still be okay for him to receive the 2nd dose later than 6 weeks, and how effective it would be if he takes it at that time. He asked that what the implications would be if he only take just 1 dose. Also he wanted to know if both doses of the Pfizer-BioNTech Covid-19 Vaccine are the same. The outcome of the event was considered as unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus got worse; This is a spontaneous report from a Non-contactable consumer(patient). A male patient0 of an unspecified age received first dose of bnt162b2 (BNT162B2, Formulation: solution for injection, Lot number : not reported) via an unspecified route of administration on 13Apr2021 as SINGLE DOSE for covid-19 immunisation. Medical history included tinnitus from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported.  On 18Apr2021, The patient experienced tinnitus got worsened and ringing in his ears has become very loud. He wanted to know if this was associated with the vaccine. He was scheduled to receive the 2nd dose of the Pfizer-BioNTech Covid-19 Vaccine in the middle of this month. The patient wants to know if the 2nd dose of the Pfizer-BioNTech Covid-19 Vaccine can be given later than 3 weeks. He also wants to know if it would still be okay for him to receive the 2nd dose later than 6 weeks, and how effective it would be if he takes it at that time. He asked that what the implications would be if he only take just 1 dose. Also he wanted to know if both doses of the Pfizer-BioNTech Covid-19 Vaccine are the same. The outcome of the event was considered as unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Headache, SARS-CoV-2 test
Clinical narrative: COVID-19; Headache; This is a spontaneous report from a contactable consumer or other non-HCP. A 53-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EN6208) via an unspecified route of administration in left arm on 06Mar2021 as single dose for covid-19 immunization. Patient was 53-years-old at the time of vaccination. The patients medical history and concomitant medications were not reported. On an unspecified date, patient experienced COVID-19 and headache. Patient was given the shot (unspecified) for the headache and was not treated for COVID-19. On an unspecified date (approximately a week after), patient underwent lab tests and procedures which included sars-cov-2 test: positive. Patient mentioned that he was scheduled to get the another shot on 15Apr2021 which was 5 or 6 days ago but he didn't do it. Patient wanted to know that for how long he needed to wait to get the second shot. The outcome of the events was unknown.   No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Seasonal allergy
Clinical narrative: experienced allergy and it only happened when smelling pollen from flowers; This is a spontaneous report from a Pfizer-sponsored program, a contactable consumer (patient). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration on 09Apr2021 (Lot number was not reported) as SINGLE DOSE for Covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient had 1st dose of the Covid-19 vaccine last April 9 and yesterday they experienced allergy and it only happened when smelling pollen from flowers. They do not have this allergy before and was only developed after taking the vaccine. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Dizziness
Clinical narrative: he only was tired after the vaccine; This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient only was tired after the vaccine so he wanted to know if he should take aspirin before and after the second covid vaccine. The outcome of event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue
Clinical narrative: he only was tired after the vaccine; This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient only was tired after the vaccine so he wanted to know if he should take aspirin before and after the second covid vaccine. The outcome of event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Blood pressure measurement, Hypertension, Nausea, Neck pain
Clinical narrative: I did not have any problem except the headache with the 1st; This is spontaneous report from a contactable consumer (patient). A 60-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at the age of 60 years old, via an unspecified route of administration administered in left arm on 16Mar2021 (Batch/Lot Number: EN6208; Expiration Date: 30Jun2021) as single dose for COVID-19 immunisation. Medical history included Diabetes Type II (Diagnosed about 5 years ago), fibromyalgia (Diagnosed about 6 years ago), high blood pressure. Concomitant medications included gabapentin taken for Diabetes type II; empagliflozin (JARDIANCE) taken for Diabetes type II; clonidine taken for high blood pressure; labetalol taken for high blood pressure. The patient did not have any problem except the headache with the 1st on an unspecified date. The outcome of the event was unknown.   No follow-up attempts are possible. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Pain in extremity, Peripheral swelling
Clinical narrative: I did not have any problem except the headache with the 1st; This is spontaneous report from a contactable consumer (patient). A 60-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at the age of 60 years old, via an unspecified route of administration administered in left arm on 16Mar2021 (Batch/Lot Number: EN6208; Expiration Date: 30Jun2021) as single dose for COVID-19 immunisation. Medical history included Diabetes Type II (Diagnosed about 5 years ago), fibromyalgia (Diagnosed about 6 years ago), high blood pressure. Concomitant medications included gabapentin taken for Diabetes type II; empagliflozin (JARDIANCE) taken for Diabetes type II; clonidine taken for high blood pressure; labetalol taken for high blood pressure. The patient did not have any problem except the headache with the 1st on an unspecified date. The outcome of the event was unknown.   No follow-up attempts are possible. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache
Clinical narrative: I did not have any problem except the headache with the 1st; This is spontaneous report from a contactable consumer (patient). A 60-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at the age of 60 years old, via an unspecified route of administration administered in left arm on 16Mar2021 (Batch/Lot Number: EN6208; Expiration Date: 30Jun2021) as single dose for COVID-19 immunisation. Medical history included Diabetes Type II (Diagnosed about 5 years ago), fibromyalgia (Diagnosed about 6 years ago), high blood pressure. Concomitant medications included gabapentin taken for Diabetes type II; empagliflozin (JARDIANCE) taken for Diabetes type II; clonidine taken for high blood pressure; labetalol taken for high blood pressure. The patient did not have any problem except the headache with the 1st on an unspecified date. The outcome of the event was unknown.   No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cerebral venous sinus thrombosis, Headache, Magnetic resonance imaging head abnormal, Tenderness, Transverse sinus thrombosis
Clinical narrative: Transverse, sigmoid sinus, and internal jugular thrombosis
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Antibody test negative, Computerised tomogram head abnormal, Fibrin D dimer, Heparin-induced thrombocytopenia test, Jugular vein thrombosis
Clinical narrative: Transverse, sigmoid sinus, and internal jugular thrombosis
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Transverse sinus thrombosis, Venogram abnormal
Clinical narrative: Transverse, sigmoid sinus, and internal jugular thrombosis
Age: 27.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cold sweat, Dizziness, Immediate post-injection reaction, Nausea
Clinical narrative: Systemic: Dizziness / Lightheadness-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Numbness (specify: facial area, extremities)-Mild, Additional Details: patient is able to recovered after sitting down for 15-20 minutes
Age: 27.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Flushing, Hyperhidrosis, Hypoaesthesia
Clinical narrative: Systemic: Dizziness / Lightheadness-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Numbness (specify: facial area, extremities)-Mild, Additional Details: patient is able to recovered after sitting down for 15-20 minutes
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Cough, Diarrhoea, Dyspnoea, Haemoptysis
Clinical narrative: Experiencing fever has not gone away; This is a spontaneous report received from Pfizer sponsored program. A contactable Male consumer (patient) reported for himself. A male patient of an unspecified age received first dose of BNT162B2 (Pfizer Covid-19 Vaccine, solution for injection, Lot Number and Expiration date was not reported) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Swap from cancer screening program. After got first dose of vaccine 19 days ago On an unspecified date the patient Experiencing fever has not gone away went to the hospital 3 times, referred to specialist for lungs, been given medicine to take". The patient received treatment for this event. The outcome of the event was not recovered.   No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Lung disorder, Malaise, Night sweats, Pyrexia
Clinical narrative: Experiencing fever has not gone away; This is a spontaneous report received from Pfizer sponsored program. A contactable Male consumer (patient) reported for himself. A male patient of an unspecified age received first dose of BNT162B2 (Pfizer Covid-19 Vaccine, solution for injection, Lot Number and Expiration date was not reported) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Swap from cancer screening program. After got first dose of vaccine 19 days ago On an unspecified date the patient Experiencing fever has not gone away went to the hospital 3 times, referred to specialist for lungs, been given medicine to take". The patient received treatment for this event. The outcome of the event was not recovered.   No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Weight decreased
Clinical narrative: Experiencing fever has not gone away; This is a spontaneous report received from Pfizer sponsored program. A contactable Male consumer (patient) reported for himself. A male patient of an unspecified age received first dose of BNT162B2 (Pfizer Covid-19 Vaccine, solution for injection, Lot Number and Expiration date was not reported) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Swap from cancer screening program. After got first dose of vaccine 19 days ago On an unspecified date the patient Experiencing fever has not gone away went to the hospital 3 times, referred to specialist for lungs, been given medicine to take". The patient received treatment for this event. The outcome of the event was not recovered.   No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: Experiencing fever has not gone away; This is a spontaneous report received from Pfizer sponsored program. A contactable Male consumer (patient) reported for himself. A male patient of an unspecified age received first dose of BNT162B2 (Pfizer Covid-19 Vaccine, solution for injection, Lot Number and Expiration date was not reported) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Swap from cancer screening program. After got first dose of vaccine 19 days ago On an unspecified date the patient Experiencing fever has not gone away went to the hospital 3 times, referred to specialist for lungs, been given medicine to take". The patient received treatment for this event. The outcome of the event was not recovered.   No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Dysphagia, Dyspnoea
Clinical narrative: Complained of worsening dizziness, chest tightness, difficulty swallowing water and mild shortness of breath.   Sent to ER
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Dizziness, Dysphagia, Dyspnoea
Clinical narrative: Complained of worsening dizziness, chest tightness, difficulty swallowing water and mild shortness of breath.   Sent to ER
Age: 22.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: Fatique; Muscle pain; HA; Tinnitus / Ringing in her ears; This is a follow up spontaneous report from a Pfizer sponsored program. A 22-years-old contactable female consumer (patient) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. Patient previously took first dose of BNT162B2 for COVID-19 Immunization. The patient medical history and concomitant medications were not reported. Patient received the series for covax a month ago (Pfizer covid vaccine 4 weeks) and still having side effects. Her-side effects started after the 2nd covax with fatigue, muscle pain and HA. Now ringing in her ears, she knew that some of the side effects resolved within a few days, but she is still having tinnitus that has still going. Patient asked how long will side effects last. She wanted to know about the duration of this side effect to know if this is permanent or not. Patient was aware that there were thousands of reports of tinnitus for the covid vaccine. Patient got response that there were no reports of Tinnitus and the duration of each side effect is different between patients. Recommended to consult her physician about treatment recommendations. The side effects reported goes away in some days, but we did not have any report that is permanent. There were unaddressed medical questions referred or forwarded to Medical Information. There was no PQC. Outcome of the events fatigue, muscle pain and headache were recovered on unspecified date. Outcome of the event ringing in her ears was not recovered. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 22.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Myalgia, Tinnitus
Clinical narrative: Fatique; Muscle pain; HA; Tinnitus / Ringing in her ears; This is a follow up spontaneous report from a Pfizer sponsored program. A 22-years-old contactable female consumer (patient) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. Patient previously took first dose of BNT162B2 for COVID-19 Immunization. The patient medical history and concomitant medications were not reported. Patient received the series for covax a month ago (Pfizer covid vaccine 4 weeks) and still having side effects. Her-side effects started after the 2nd covax with fatigue, muscle pain and HA. Now ringing in her ears, she knew that some of the side effects resolved within a few days, but she is still having tinnitus that has still going. Patient asked how long will side effects last. She wanted to know about the duration of this side effect to know if this is permanent or not. Patient was aware that there were thousands of reports of tinnitus for the covid vaccine. Patient got response that there were no reports of Tinnitus and the duration of each side effect is different between patients. Recommended to consult her physician about treatment recommendations. The side effects reported goes away in some days, but we did not have any report that is permanent. There were unaddressed medical questions referred or forwarded to Medical Information. There was no PQC. Outcome of the events fatigue, muscle pain and headache were recovered on unspecified date. Outcome of the event ringing in her ears was not recovered. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Burning sensation, Computerised tomogram, Headache, Herpes zoster
Clinical narrative: Headache at work after vaccine; leg very sensitive and burning feeling; leg very sensitive and burning feeling; very severe stomach pain-Dr appt and ER; shingles; This is a spontaneous report from a contactable other health professional (patient). A 61-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration (at the age of 61-years-old), administered in Arm Left on 28Jan2021 09:00 (Batch/Lot number was not reported) as single dose for COVID-19 immunization. Medical history included concussion (years ago) and endometriosis (decades ago). The patient was not pregnant. Not diagnosed with COVID prior vaccination. No known allergies. Concomitant medications included estradiol (ESTROGEN) patch and progesterone cream: taken for unspecified indications, start and stop dates were not reported. The patient experienced headache at work after vaccine, then got more severe along with leg very sensitive and burning feeling (all on on 28Jan2021 09:00), better then 5 nights very severe stomach pain (unspecified date in 2021)-Dr appt and ER to get sonogram, CT. Very late diagnosing as shingles on an unspecified date in 2021. The events resulted in emergency room visit and physician office visit. The patient underwent lab tests and procedures which included computerised tomogram: shingles on 2021 and ultrasound scan: shingles on 2021. Therapeutic measures were taken as a result of the events. The outcome of the events was not recovered. The vaccine facility type was hospital. No other vaccine in four weeks. Not tested for COVID post vaccination.  Information on the lot/batch number has been requested.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sensory disturbance, Ultrasound scan
Clinical narrative: Headache at work after vaccine; leg very sensitive and burning feeling; leg very sensitive and burning feeling; very severe stomach pain-Dr appt and ER; shingles; This is a spontaneous report from a contactable other health professional (patient). A 61-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration (at the age of 61-years-old), administered in Arm Left on 28Jan2021 09:00 (Batch/Lot number was not reported) as single dose for COVID-19 immunization. Medical history included concussion (years ago) and endometriosis (decades ago). The patient was not pregnant. Not diagnosed with COVID prior vaccination. No known allergies. Concomitant medications included estradiol (ESTROGEN) patch and progesterone cream: taken for unspecified indications, start and stop dates were not reported. The patient experienced headache at work after vaccine, then got more severe along with leg very sensitive and burning feeling (all on on 28Jan2021 09:00), better then 5 nights very severe stomach pain (unspecified date in 2021)-Dr appt and ER to get sonogram, CT. Very late diagnosing as shingles on an unspecified date in 2021. The events resulted in emergency room visit and physician office visit. The patient underwent lab tests and procedures which included computerised tomogram: shingles on 2021 and ultrasound scan: shingles on 2021. Therapeutic measures were taken as a result of the events. The outcome of the events was not recovered. The vaccine facility type was hospital. No other vaccine in four weeks. Not tested for COVID post vaccination.  Information on the lot/batch number has been requested.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hyperaesthesia, Ultrasound scan
Clinical narrative: Headache at work after vaccine; leg very sensitive and burning feeling; leg very sensitive and burning feeling; very severe stomach pain-Dr appt and ER; shingles; This is a spontaneous report from a contactable other health professional (patient). A 61-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration (at the age of 61-years-old), administered in Arm Left on 28Jan2021 09:00 (Batch/Lot number was not reported) as single dose for COVID-19 immunization. Medical history included concussion (years ago) and endometriosis (decades ago). The patient was not pregnant. Not diagnosed with COVID prior vaccination. No known allergies. Concomitant medications included estradiol (ESTROGEN) patch and progesterone cream: taken for unspecified indications, start and stop dates were not reported. The patient experienced headache at work after vaccine, then got more severe along with leg very sensitive and burning feeling (all on on 28Jan2021 09:00), better then 5 nights very severe stomach pain (unspecified date in 2021)-Dr appt and ER to get sonogram, CT. Very late diagnosing as shingles on an unspecified date in 2021. The events resulted in emergency room visit and physician office visit. The patient underwent lab tests and procedures which included computerised tomogram: shingles on 2021 and ultrasound scan: shingles on 2021. Therapeutic measures were taken as a result of the events. The outcome of the events was not recovered. The vaccine facility type was hospital. No other vaccine in four weeks. Not tested for COVID post vaccination.  Information on the lot/batch number has been requested.
Age: 28.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Bell's palsy
Clinical narrative: Bells palsy on the right
Age: 28.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Facial paralysis
Clinical narrative: Bells palsy on the right
Age: 28.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Bell's palsy, Computerised tomogram head normal
Clinical narrative: Bells palsy on the right
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Injection site vesicles
Clinical narrative: presents with redness and blisters at the mid during a vaccine injection site on his right forearm.  The patient states he received his second injection about 2 days ago, instantly developed redness at the injection site.  However, he awoke this morning and he had large blisters.  Patient states the arm does not itch and he does not have pain, he does describe it as burning sensation in his upper arm.  The patient denies fever, shortness of breath, cough, facial swelling, numbness and tingling down the arm, pain in his arm.  There is a large area of erythema surrounding the injection sites with 2 large bullous appearing blisters.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site vesicles
Clinical narrative: presents with redness and blisters at the mid during a vaccine injection site on his right forearm.  The patient states he received his second injection about 2 days ago, instantly developed redness at the injection site.  However, he awoke this morning and he had large blisters.  Patient states the arm does not itch and he does not have pain, he does describe it as burning sensation in his upper arm.  The patient denies fever, shortness of breath, cough, facial swelling, numbness and tingling down the arm, pain in his arm.  There is a large area of erythema surrounding the injection sites with 2 large bullous appearing blisters.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blister, Erythema, Pain, Swelling
Clinical narrative: presents with redness and blisters at the mid during a vaccine injection site on his right forearm.  The patient states he received his second injection about 2 days ago, instantly developed redness at the injection site.  However, he awoke this morning and he had large blisters.  Patient states the arm does not itch and he does not have pain, he does describe it as burning sensation in his upper arm.  The patient denies fever, shortness of breath, cough, facial swelling, numbness and tingling down the arm, pain in his arm.  There is a large area of erythema surrounding the injection sites with 2 large bullous appearing blisters.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Laboratory test, Pulmonary thrombosis
Clinical narrative: Patient with no prior significant past medical history presented with bilateral pulmonary embolisms. No other provoking factors were identified besides receiving the covid-19 vaccine.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pulmonary embolism
Clinical narrative: Patient with no prior significant past medical history presented with bilateral pulmonary embolisms. No other provoking factors were identified besides receiving the covid-19 vaccine.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Alanine aminotransferase, Arthralgia, Aspartate aminotransferase, Back pain, Blood alkaline phosphatase
Clinical narrative: 05/05/21-around 9 hours after vaccination developed chest pressure and mild shortness of breath.  Symptoms worsened over the next 2 days and on 5/7/21 pain intensified.  Pain is described as chest pressure, shoulder and back pain, and also endorsed shortness of breath due to tightness and constriction. 05/07/21-presented to ED in the morning and was admitted to the Coronary Care Unit, treated with colchicine, NSAIDs resulting in gradual improvement of his symptoms.  Given response to treatment and EKG changes the presumptive diagnosis of pericarditis was confirmed.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood bilirubin, Blood calcium, Blood creatine phosphokinase, Blood creatine phosphokinase MB, Blood creatinine
Clinical narrative: 05/05/21-around 9 hours after vaccination developed chest pressure and mild shortness of breath.  Symptoms worsened over the next 2 days and on 5/7/21 pain intensified.  Pain is described as chest pressure, shoulder and back pain, and also endorsed shortness of breath due to tightness and constriction. 05/07/21-presented to ED in the morning and was admitted to the Coronary Care Unit, treated with colchicine, NSAIDs resulting in gradual improvement of his symptoms.  Given response to treatment and EKG changes the presumptive diagnosis of pericarditis was confirmed.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood electrolytes, Blood glucose, Blood magnesium, Blood phosphorus, Blood thyroid stimulating hormone
Clinical narrative: 05/05/21-around 9 hours after vaccination developed chest pressure and mild shortness of breath.  Symptoms worsened over the next 2 days and on 5/7/21 pain intensified.  Pain is described as chest pressure, shoulder and back pain, and also endorsed shortness of breath due to tightness and constriction. 05/07/21-presented to ED in the morning and was admitted to the Coronary Care Unit, treated with colchicine, NSAIDs resulting in gradual improvement of his symptoms.  Given response to treatment and EKG changes the presumptive diagnosis of pericarditis was confirmed.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood urea, C-reactive protein, Chest discomfort, Chest pain, Dyspnoea
Clinical narrative: 05/05/21-around 9 hours after vaccination developed chest pressure and mild shortness of breath.  Symptoms worsened over the next 2 days and on 5/7/21 pain intensified.  Pain is described as chest pressure, shoulder and back pain, and also endorsed shortness of breath due to tightness and constriction. 05/07/21-presented to ED in the morning and was admitted to the Coronary Care Unit, treated with colchicine, NSAIDs resulting in gradual improvement of his symptoms.  Given response to treatment and EKG changes the presumptive diagnosis of pericarditis was confirmed.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram abnormal, Full blood count, Glycosylated haemoglobin, Influenza A virus test, Influenza B virus test
Clinical narrative: 05/05/21-around 9 hours after vaccination developed chest pressure and mild shortness of breath.  Symptoms worsened over the next 2 days and on 5/7/21 pain intensified.  Pain is described as chest pressure, shoulder and back pain, and also endorsed shortness of breath due to tightness and constriction. 05/07/21-presented to ED in the morning and was admitted to the Coronary Care Unit, treated with colchicine, NSAIDs resulting in gradual improvement of his symptoms.  Given response to treatment and EKG changes the presumptive diagnosis of pericarditis was confirmed.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Lipids, Metabolic function test, Muscle contractions involuntary, Muscle twitching, Neck pain
Clinical narrative: 05/05/21-around 9 hours after vaccination developed chest pressure and mild shortness of breath.  Symptoms worsened over the next 2 days and on 5/7/21 pain intensified.  Pain is described as chest pressure, shoulder and back pain, and also endorsed shortness of breath due to tightness and constriction. 05/07/21-presented to ED in the morning and was admitted to the Coronary Care Unit, treated with colchicine, NSAIDs resulting in gradual improvement of his symptoms.  Given response to treatment and EKG changes the presumptive diagnosis of pericarditis was confirmed.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pericarditis, Prothrombin time, Red blood cell sedimentation rate, Respiratory syncytial virus test, SARS-CoV-2 test
Clinical narrative: 05/05/21-around 9 hours after vaccination developed chest pressure and mild shortness of breath.  Symptoms worsened over the next 2 days and on 5/7/21 pain intensified.  Pain is described as chest pressure, shoulder and back pain, and also endorsed shortness of breath due to tightness and constriction. 05/07/21-presented to ED in the morning and was admitted to the Coronary Care Unit, treated with colchicine, NSAIDs resulting in gradual improvement of his symptoms.  Given response to treatment and EKG changes the presumptive diagnosis of pericarditis was confirmed.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Troponin I
Clinical narrative: 05/05/21-around 9 hours after vaccination developed chest pressure and mild shortness of breath.  Symptoms worsened over the next 2 days and on 5/7/21 pain intensified.  Pain is described as chest pressure, shoulder and back pain, and also endorsed shortness of breath due to tightness and constriction. 05/07/21-presented to ED in the morning and was admitted to the Coronary Care Unit, treated with colchicine, NSAIDs resulting in gradual improvement of his symptoms.  Given response to treatment and EKG changes the presumptive diagnosis of pericarditis was confirmed.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute myocardial infarction, Arthralgia, Back pain, Blood calcium normal, Blood chloride normal
Clinical narrative: 05/05/21-around 9 hours after vaccination developed chest pressure and mild shortness of breath.  Symptoms worsened over the next 2 days and on 5/7/21 pain intensified.  Pain is described as chest pressure, shoulder and back pain, and also endorsed shortness of breath due to tightness and constriction. 05/07/21-presented to ED in the morning and was admitted to the Coronary Care Unit, treated with colchicine, NSAIDs resulting in gradual improvement of his symptoms.  Given response to treatment and EKG changes the presumptive diagnosis of pericarditis was confirmed.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood creatinine normal, Blood glucose increased, Blood potassium normal, Blood sodium normal, Blood urea decreased
Clinical narrative: 05/05/21-around 9 hours after vaccination developed chest pressure and mild shortness of breath.  Symptoms worsened over the next 2 days and on 5/7/21 pain intensified.  Pain is described as chest pressure, shoulder and back pain, and also endorsed shortness of breath due to tightness and constriction. 05/07/21-presented to ED in the morning and was admitted to the Coronary Care Unit, treated with colchicine, NSAIDs resulting in gradual improvement of his symptoms.  Given response to treatment and EKG changes the presumptive diagnosis of pericarditis was confirmed.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Carbon dioxide normal, Chest X-ray normal, Chest discomfort, Dyspnoea, Electrocardiogram abnormal
Clinical narrative: 05/05/21-around 9 hours after vaccination developed chest pressure and mild shortness of breath.  Symptoms worsened over the next 2 days and on 5/7/21 pain intensified.  Pain is described as chest pressure, shoulder and back pain, and also endorsed shortness of breath due to tightness and constriction. 05/07/21-presented to ED in the morning and was admitted to the Coronary Care Unit, treated with colchicine, NSAIDs resulting in gradual improvement of his symptoms.  Given response to treatment and EKG changes the presumptive diagnosis of pericarditis was confirmed.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Haematocrit decreased, Haemoglobin decreased, Pericarditis, Platelet count normal, Troponin increased
Clinical narrative: 05/05/21-around 9 hours after vaccination developed chest pressure and mild shortness of breath.  Symptoms worsened over the next 2 days and on 5/7/21 pain intensified.  Pain is described as chest pressure, shoulder and back pain, and also endorsed shortness of breath due to tightness and constriction. 05/07/21-presented to ED in the morning and was admitted to the Coronary Care Unit, treated with colchicine, NSAIDs resulting in gradual improvement of his symptoms.  Given response to treatment and EKG changes the presumptive diagnosis of pericarditis was confirmed.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: White blood cell count increased
Clinical narrative: 05/05/21-around 9 hours after vaccination developed chest pressure and mild shortness of breath.  Symptoms worsened over the next 2 days and on 5/7/21 pain intensified.  Pain is described as chest pressure, shoulder and back pain, and also endorsed shortness of breath due to tightness and constriction. 05/07/21-presented to ED in the morning and was admitted to the Coronary Care Unit, treated with colchicine, NSAIDs resulting in gradual improvement of his symptoms.  Given response to treatment and EKG changes the presumptive diagnosis of pericarditis was confirmed.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Ear congestion, Hypoacusis, Tinnitus
Clinical narrative: Ringing started in my left ear within 48 hours of 2nd vaccination shot (same side as injection arm).  The ringing has been persistent, continuous, and continues today, three and one half weeks after receiving the second dose.  The ringing has NOT been accompanied with other sinus related symptoms, like congestion, stuffy nose, etc.  I have experienced a mild plugged-ear like symptom in my right ear, but not ringing in the right ear.  This also persists today.  The intensity of the ringing in my left ear varies slightly from time to time, without any understood correlation.  The ringing intensity is high enough to impact my hearing of conversational speech, but not so severe to impact sleeping. Overall, the intensity of the ringing  has not diminished, and may even be increasing slightly.  I have not received any medical advice yet, but plan to make an appointment with my doctor as soon as possible.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Immediate post-injection reaction, Pain in extremity
Clinical narrative: Immidiately following vaccine sharp stinging pain in mid arm that intermittently comes and goes. Persisting unchanged to today
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Arthralgia, Burning sensation, Fatigue, Herpes zoster
Clinical narrative: Had severe joint pain and fatigue from 04/26/21-05/02/21, then woke up in the middle of the night with a burning sensation to left side of abdomen and flank. Severe numbness and burning from (05/02-05/07), diagnosed with Neuralgia 05/07 /21, then developed rash the night of 05/07/21. Went to urgent care the morning of 05/08 and diagnosed with Shingles. Prescribed Neurontin and Lyrica for Shingles. I do not have any auto-immmune disorders diagnosed currently but have been tested in the past, not immunocompromised, not under stress, and I have not been exposed to anyone with Shingles or chickenpox.